Mast Therapeutics, Inc. (MSTX)

[Jummbo29]

Very nice.

Today I feel (for various reasons I won't bore you with) that ANX, given the circumstances, behaved differently than a typical microcap should have behaved today. I've been around these for a long time. I'm buying ANX profusely during this healthy tug-of-war in the low .30s. If I have to sell some for profits again, I will.

Waiting for Culley to speak Friday: https://news.fidelity.com/news/news.jhtml?articleid=201001190805STREETCMREALTIME_10662919&IMG=N&cat=default&ccsource=rss-default

"I did hear from Adventrx's CEO Brian Culley over the weekend, who thinks I'm under-estimating ANX-530's commercial potential in part because the drug is likely to receive third-party and Medicare reimbursement. I asked him to explain his reasoning in more detail and make the bull case for ANX-530, which he agreed to do. I will post his comments in Friday's Biotech Stock Mailbag."